INmune Bio Insider Trades
NASDAQ: INMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
INmune Bio insider activity
Over the last 12 months, INmune Bio insiders reported 3 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Lowdell Mark William (Chief Scientific Officer) reporting a transaction in 7,211 shares at $1.40 on Jul 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put INMB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
INMB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 2, 2026 | Juda ScottDirector | Option exercise | 14,801 | $20.72K | Form 4 |
| Jul 2, 2026 | Moss David JChief Executive Officer | Option exercise | 9,014 | $12.62K | Form 4 |
| Jul 2, 2026 | Lowdell Mark WilliamChief Scientific Officer | Option exercise | 7,211 | $10.10K | Form 4 |
| Sep 30, 2024 | Moss David JChief Financial Officer | Buy | 10,000 | $52.87K | Form 4 |
| Sep 12, 2024 | Tesi Raymond JosephPresident and CEO | Buy | 15,380 | $98.05K | Form 4 |
| Sep 12, 2024 | Moss David JChief Financial Officer | Buy | 7,690 | $49.02K | Form 4 |
| Jun 25, 2024 | Juda ScottDirector | Buy | 5,000 | $36.35K | Form 4 |
| Apr 19, 2024 | Moss David JCFO, Treasurer & Secretary | Buy | 18,028 | $149.99K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4